Bendtzen K, Rieneck K, Hansen PR, Mazzarino MC, Di Marco R, Nicoletti F, the Spironolactone/Arthritis Study Group. Spironolactone inhibits production of proinflammatory cytokines and has potential as a new anti-inflammatory drug. J Interferon Cytokine Res 2002;22, Suppl.1:191-2. Christensen H, Boysen G, Christensen E, Johannesen HH, Bendtzen K. Plasma cytokines in acute stroke. J Stroke Cerebrovasc Dis 2002;11:72-9. Christensen H, Boysen G, Johannesen H, Christensen E, Bendtzen K. Deteriorating ischaemic stroke: cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J Neurol Sci 2002; 201: 1-7. Graudal N, Svenson M, Tarp U, Garred P, Jurik A-G, Bendtzen K. Autoantibodies against interleukin 1a in rheumatoid arthritis: Association with long-term radiographic outcome. Ann Rheum Dis 2002;61:598-602. Abstract. Hyllested JL, Veje K, Østergaard K. Histochemical studies of the extracellular matrix of human articular cartilage-a review. Osteoarthritis Cartilage 2002;10:333-43. Kronborg G, Østergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, Price PA, Johansen JS. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002;34:323-6. Li L, Itoh M, Ablake M, Macri B, Bendtzen K, Nicoletti F. Prevention of murine experimental autoimmune orchitis by recombinant human interleukin-6. Clin Immunol 2002;102:135-7. Abstract. Manniche C, Østergaard K, Jordan A. Træning af ryg og nakke år 2002. Ugeskr Laeger 2002; 164: 1910-3. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, Bjorkander J, Olsen JH. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002;130:495-500. Nersting J, Andersen V, Bendtzen K. Autoinflammatoriske sygdomme: et nyt begreb (Review in Danish). Ugeskr Laeger 2002; 164: 4269-71. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino MC, Bendtzen K et al. Serum levels of the interferon-g-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type 1 diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 2002; 45: 1107-10. Abstract. Nielsen CH, Leslie RG. Complement's participation in acquired immunity. J Leukoc Biol 2002;72:249-61. Nielsen CH, Pedersen ML, Marquart HV, Prodinger WM, Leslie RG. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells. Eur J Immunol 2002;32:1359-67. Papaccio G, Nicoletti F, Pisanti FA, Galdieri M, Bendtzen K. An imidazoline compound completely counteracts interleukin-1b toxic effects to rat pancreatic islet beta-cells. Mol Med 2002;8:536-45. Abstract. Petersen SL, Russell CA, Bendtzen K, Vindeløv LL. Optimisation of the CT.h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohemagglutinin or by human leukocyte antigen-mismatched mixed lymphocyte culture. Immunol Lett 2002; 84: 29-39. Ross C, Engler CB, Sander B, Bendtzen K. IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-a2a. J Interferon Cytokine Res 2002;22: 421-426. Veje K, Hyllested J, Østergaard K. Osteoartrose. Patogenese, klinik og behandling. Ugeskr Læger 2002; 164: 3173-9. (Review).
2002
Written publications
Peer-reviewed articles:
